During the past decade, Fundacion Cardioinfantil conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 15 clinical trials were completed, i.e. on average, 46.9% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundacion Cardioinfantil" #1 sponsor was "Allievex Corporation" with 5 trials, followed by "Fundación Cardioinfantil Instituto de Cardiología" with 5 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials sponsored and "Mirum Pharmaceuticals, Inc." with 4 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion Cardioinfantil" #1 collaborator was "Fundación Cardioinfantil Instituto de Cardiología" with 4 trials as a collaborator, "Hospital Universitario San Ignacio" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Ankara University" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Fundacion Cardioinfantil" are "MPS III B" (4 trials), "Mucopolysaccharidosis Type IIIB" (4 trials), "Heart Failure" (3 trials), "COVID-19" (2 trials) and "Cardiovascular Health" (2 trials). Many other conditions were trialed in "Fundacion Cardioinfantil" in a lesser frequency.

Most popular intervention types in "Fundacion Cardioinfantil" are "Drug" (27 trials), "Other" (10 trials), "Device" (5 trials), "Procedure" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "AX 250" (3 trials), "Cyclophosphamide" (3 trials), "Doxorubicin" (3 trials) and "Conventional care" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion Cardioinfantil" are 45 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Fundacion Cardioinfantil". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 25 completed trials in Fundacion Cardioinfantil, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion Cardioinfantil, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 8 trials that are defined as “Not Applicable".